Scientists developed a clinically relevant transplantation strategy synergizing hydrogel-mediated delivery and engineered human myogenic progenitor cells generated from CRISPR-corrected Duchenne muscular dystrophy patient-derived pluripotent stem cells.
[Cell Reports Medicine]